| Neuroendocrine carcinoma of the vagina in pregnancy. | |
| | |
MedLine Citation:
|
PMID: 22270433 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
BACKGROUND: : Neuroendocrine carcinoma of the vagina is extremely rare. Treatment options in pregnancy are complex owing to the aggressive tumor type and poor prognosis. CASE: : We report the case of a gravid woman diagnosed with stage IVB neuroendocrine carcinoma of the vagina at 16 weeks of gestation. Disease responded to chemotherapy, and pregnancy was continued until onset of preterm labor at 28 5/7 weeks of gestation, with subsequent delivery of a viable fetus. Despite aggressive treatment with chemoradiation postpartum, the patient died of progressive disease 11 months after initial diagnosis. CONCLUSION: : A multidisciplinary team should review treatment options and potential complications with the patient. Because of the tendency toward early tumor dissemination, the optimal treatment for neuroendocrine carcinoma in pregnancy involves systemic chemotherapy. |
| | |
Authors:
|
Adam C Elnaggar; Avinash S Patil; Krishna Singh; Mark E Reed |
Related Documents
:
|
3745493 - Black adolescent pregnancy: prevention and management. 22339273 - Induction at 41 weeks increases the risk of caesarean section in a hospital with a low ... 9848763 - Intraperitoneal administration of cytomegalovirus hyperimmunoglobulin to the cytomegalo... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Obstetrics and gynecology Volume: 119 ISSN: 1873-233X ISO Abbreviation: Obstet Gynecol Publication Date: 2012 Feb |
Date Detail:
|
Created Date: 2012-01-24 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0401101 Medline TA: Obstet Gynecol Country: United States |
Other Details:
|
Languages: eng Pagination: 445-7 Citation Subset: AIM; IM |
Affiliation:
|
From the Department of Obstetrics and Gynecology, University of Tennessee Health Science Center, and the Division of Gynecologic Oncology, University of Tennessee-West Clinic, Memphis, Tennessee; and the Divisions of Maternal-Fetal Medicine, Duke University Medical Center, Durham, North Carolina, and Cedars-Sinai Medical Center, Los Angeles, California. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Treatment of Multifocal Bowen's Disease in Immunocompromised Women With Surgery and Topical Imiquimo...
Next Document: Raynaud's Phenomenon of the Nipple.